Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Outcomes Based on Age in the Phase III METEOR Trial of Cabozantinib Versus Everolimus in Patients With Advanced Renal Cell CarcinomaEur. J. Cancer 2020 Feb 01;126(xx)1-10, F Donskov, RJ Motzer, E Voog, E Hovey, C Grüllich, LM Nott, K Cuff, T Gil, NV Jensen, C Chevreau, S Negrier, R Depenbusch, L Bergmann, I Cornelio, A Champsaur, B Escudier, S Pal, T Powles, TK Choueiri
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.